The SHINGLARIX brand, founded in 2007 (Belgium), from 1722 sister brands and 17479 competing brands. The SHINGLARIX brand is owned by GSK PLC, a company listed in London. The ISIN, the company's International Securities Identification Number, is GB00BN7SWP63. SHINGLARIX is part of the Drug Manufacturers activity sector.

SHINGLARIX is a brand of GSK PLC (GSK/L)